mitomycin has been researched along with Conductive Hearing Loss in 1 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The results of this study indicate that topical mitomycin C on Gelfoam applied in the middle ear appears safe when low concentrations are used, even in the rat, which has a higher susceptibility to gentamycin toxicity than humans." | 2.71 | Otologic effects of topical mitomycin C: phase I-evaluation of ototoxicity. ( Babu, SC; Kartush, JM; Patni, A, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babu, SC | 1 |
| Kartush, JM | 1 |
| Patni, A | 1 |
1 trial available for mitomycin and Conductive Hearing Loss
| Article | Year |
|---|---|
Otologic effects of topical mitomycin C: phase I-evaluation of ototoxicity.
Topics: Administration, Topical; Animals; Antibiotics, Antineoplastic; Auditory Threshold; Cicatrix; Dose-Re | 2005 |